Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Ralliant Corp (NYSE: RAL) represents a compelling pure-play investment in mission-critical precision technologies following its successful spin-off from Fortive Corporation in June 2025. The company is uniquely positioned to capitalize on secular growth vectors across Utilities (grid modernization), Defense & Space, and Power Electronics. Backed by the rigorous Ralliant Business System (RBS) for continuous operational improvement, Ralliant is demonstrating strong execution, as evidenced by its Q1 2026 earnings beat, raised full-year guidance, and a defense backlog surpassing $1 billion. With a disciplined capital allocation strategy prioritizing organic reinvestment, a newly expanded share buyback program, and a commitment to return 50% of free cash flow to shareholders, Ralliant offers a highly attractive combination of high-quality organic growth and robust cash generation.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets10 analysts · as of 18 Aug 2026
Low · most bearish analyst$58.00
Mean target$77.10
High · most bullish analyst$85.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$58.0015%

Macroeconomic headwinds or supply chain disruptions delay deliveries within the defense and utilities segments, causing revenue growth to stall. Tariff exposure exceeds the managed $25 million threshold, compressing margins. Integration challenges with tuck-in acquisitions or slower-than-expected adoption of the Ralliant Business System across newly independent operations limit margin expansion.

Base CaseCentral scenario
$77.1060%
Matches the consensus mean

Ralliant delivers on its raised FY 2026 guidance, achieving revenue between $2.185 billion and $2.245 billion and Adjusted EBITDA margins of 19.5% to 20.5%. The company maintains a book-to-bill ratio above 1.1x, supported by steady execution of its $1 billion defense backlog. Capital return initiatives, including the $200 million share repurchase authorization, provide solid downside support for the stock.

Bull CaseUpside scenario
$85.0025%

Accelerated adoption of grid modernization and power electronics drives organic revenue growth above the 3-5% long-term target. The enterprise productivity program yields higher-than-expected cost savings, pushing Adjusted EBITDA margins past 21% in FY 2026. Rapid deployment of the $27.3 million Defense Production Act investment at PacSci EMC scales production of arm fire devices ahead of schedule, capturing additional high-margin defense contracts.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Pure-play exposure to high-barrier, secular growth markets including grid modernization, defense, and power electronics.
  • Strong operational foundation rooted in the Ralliant Business System (RBS), driving continuous margin expansion and high free cash flow conversion (historically >105% TTM).
  • Robust revenue visibility supported by a defense backlog exceeding $1 billion.
  • Shareholder-friendly capital allocation with a $200 million buyback authorization and a commitment to return 50% of free cash flow to shareholders.
Sign in / Sign up to read more
Key Investment Risks
  • Sensitivity to global macroeconomic cycles and capital expenditure budgets of utility and semiconductor customers.
  • Geopolitical and supply chain risks, including tariff exposures projected at approximately $25 million for 2026.
  • Execution risk associated with scaling production capacity to meet the rapid backlog expansion in the defense segment.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Book-to-bill ratio falling below 1.0x for two consecutive quarters, indicating a slowdown in order momentum.
  2. Adjusted EBITDA margins compressing below 18% due to unmitigated tariff costs or operational inefficiencies.
  3. Significant delays or cost overruns in the capacity expansion projects funded by the Defense Production Act.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.